Greenberg Traurig 1900 University Ave 5Fl, East Palo Alto, CA 94303 (650)3288500 (Office), (650)3288508 (Fax)
Licenses:
California - Active 1999
Education:
University of North Carolina, Chapel Hill Degree - PhD - Doctorate Peking University Degree - BS - Bachelor of Science University of California at Berkeley, Boalt Hall School of Law Degree - JD - Juris Doctor - Law
Specialties:
Intellectual Property - 100%
Languages:
English Mandarin
Associations:
American Bar Association - Member American Business Trial Lawyers Association - Member
Winston Salem Baptist Medical Center IM Medical Ctr Blvd Jane Way Tower 4 7 Floor, Winston Salem, NC 27157 (336)7163182 (phone), (336)7165168 (fax)
Education:
Medical School Hebei Med Univ, Shi Jiazhuang City, Hebei, China Graduated: 1996
Procedures:
Bone Marrow Biopsy
Languages:
English Spanish
Description:
Dr. Li graduated from the Hebei Med Univ, Shi Jiazhuang City, Hebei, China in 1996. She works in Winston-Salem, NC and specializes in Internal Medicine. Dr. Li is affiliated with Wake Forest Baptist Medical Center.
Dr. Li graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. She works in Irvine, CA and specializes in Family Medicine and Acupuncturist. Dr. Li is affiliated with St Joseph Hospital Of Orange.
Computer Resource Center, the Department of Parks and Recreation New York, NY Feb 2011 to Oct 2011 Contracted Administrative AssistantThe Pioneer Newspaper, California State University, Eastbay, CA
Jan 2005 to Feb 2006 Sales Executive - InternSouth Center University for Nationalities Wuhan, CN Jul 1988 to Dec 1996 Lecturer/ Teaching Assistant (full-time)
Education:
California State University Hayward, CA 2004 to 2009 MBA in finance 80% completedWuhan University Wuhan, CN 1984 to 1988 BA in Law
Skills:
Macrosoft Office in word, excel and ppt. Adobe Primere Elements10, Chinese & English,
TE Connectivity Menlo Park, CA Sep 2011 to Sep 2012 Manufacturing Development EngineerAsteelFlash Fremont, CA Feb 2011 to Sep 2011 Project Manufacturing EngineerState University of New York (SUNY) Binghamton, NY Sep 2007 to May 2010 Graduate Research AssociateSMT Assembly Consortium Lab, Unovis Solutions Binghamton, NY Aug 2005 to Aug 2007 Graduate Research Associate
Education:
State University of New York (SUNY) Binghamton, NY Dec 2007 to Dec 2010 Doctor of philosophy (Ph.D.) in Industrial & Systems EngineeringState University of New York (SUNY) Binghamton, NY Sep 2005 to Dec 2007 Master of Science in Industrial & Systems EngineeringXi'an Jiaotong University Sep 2000 to Jul 2005 Bachelor of Science in Industrial EngineeringXi'an Jiaotong University Bachelor of Science in Business Management
Oct 2013 to 2000 Data Analystgoogle Mountain View, CA Jul 2012 to Jul 2013 Data Analyst (Contractor)Hermes Microvision Inc Milpitas, CA Jan 2012 to Jul 2012 Data Analyst Intern
Education:
State University of New York at Buffalo Buffalo, NY 2009 to 2011 Master in Science in Electrical EngineeringHuazhong University of Science and Technology Wuhan, China 2004 to 2008 Bachelor in Science in Telecommunication Engineering
Hossein Dehghan - Danville CA Ramon A. Cruz - Fremont CA Jing Li - San Jose CA
Assignee:
LSI Logic Corporation - Milpitas CA
International Classification:
H04L 512
US Classification:
375261, 375264, 375353
Abstract:
A method for determining the signal constellation of a received signal establishes a moment based on each waveform, squares the moment, fourth powers the moment, divides the fourth power by the square to obtain a ratio, and compares the ratio to a threshold. If the ratio is less than threshold, the signal constellation corresponds to a first type, and if greater than the threshold, the signal constellation corresponds to a second type. The method can be generalized to a magnitude mean in place of a second moment.
Synthetic Diazonamides As Novel Anti-Mitotic Agents
Patrick G. Harran - Dallas TX, US Jing Li - Dallas TX, US Susan Jeong - Dallas TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61P 35/00 A61K 31/42 A61K 31/425 C07D 487/00
US Classification:
514366, 514375, 540457
Abstract:
The application discloses novel synthetic compounds, modeled after unique toxins extracted from the marine invertebrate useful in the treatment abnormal cell mitosis. The application also discloses novel methods for synthesis of these compounds and methods of using these compounds.
Zhenkun Ma - Dallas TX, US In Ho Kim - Lewisville TX, US Jing Li - Dallas TX, US
Assignee:
Cumbre Pharmaceuticals Inc. - Dallas TX
International Classification:
C07D 225/04 A61K 31/495 A61P 31/04
US Classification:
514250, 540453, 540457
Abstract:
Compounds of the current invention relate to rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms. More specifically, compounds of the current invention relate to a series of novel spiro rifamycin derivatives which have demonstrated potent antimicrobial activity.
(R/S) Rifamycin Derivatives, Their Preparations And Pharmaceutical Compositions
Charles Z. Ding - Plano TX, US Zhenkun Ma - Dallas TX, US Jing Li - Dallas TX, US Susan Harran - Dallas TX, US Yong He - Arlington TX, US Keith P. Minor - Dallas TX, US In Ho Kim - Lewisville TX, US Jamie C. Longgood - Carrollton TX, US Yafei Jin - Dallas TX, US Keith D. Combrink - Fort Worth TX, US
Assignee:
Cumbre Pharmaceuticals Inc. - Dallas TX
International Classification:
C07D 498/08 A61K 31/4709 A61P 31/04
US Classification:
514306, 540458, 548138, 548208
Abstract:
Rifamycin derivatives having the following structure of general formula I (both hydroquinone and corresponding quinone (C-C) forms):.
Zhenkun Ma - Dallas TX, US Jing Li - Dallas TX, US Susan Harran - Dallas TX, US Yong He - Arlington TX, US Keith P. Minor - Dallas TX, US In Ho Kim - Lewisville TX, US Charles Z. Ding - Plano TX, US Jamie C. Longgood - Carrolton TX, US Yafei Jin - Dallas TX, US Keith D. Combrink - Fort Worth TX, US
Assignee:
Cumbre Pharmaceuticals Inc. - Dallas TX
International Classification:
C07D 498/08 A61K 31/4709 A61P 31/04
US Classification:
51425217, 514278, 514306, 540459
Abstract:
Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C-C) forms):.
Rifamycin Imino Derivatives Effective Against Drug-Resistant Microbes
Charles Z. Ding - Plano TX, US Yafei Jin - Dallas TX, US Jamie C. Longgood - Carrollton TX, US Zhenkun Ma - Dallas TX, US Jing Li - Dallas TX, US In Ho Kim - Flower Mound TX, US Keith P. Minor - Dallas TX, US Susan Harran - Dallas TX, US
The present invention relates to rifamycin 3-iminomethylenyl (—CH═N—) derivatives having antimicrobial activities, including activities against drug-resistant microorganisms. The claimed rifamycin derivative has a rifamycin moiety covalently linked to a linker through an iminomethylenyl (—CH═N—) group at the C-3 carbon of the rifamycin moiety and the linker is, in turn, covalently linked to a quinolone structure or its pharmacophore within the DNA gyrase and topoisomerase IV inhibitor family. The inventive rifamycins are novel and exhibit activity against both rifampin and ciprofloxacin-resistant microorganisms.
Rifamycin Derivatives Effective Against Drug-Resistant Microbes
Zhenkun Ma - Dallas TX, US Yafei Jin - Dallas TX, US Jing Li - Dallas TX, US Charles Z. Ding - Plano TX, US Keith P. Minor - Dallas TX, US Jamie C. Longgood - Carrollton TX, US In Ho Kim - Flower Mound TX, US Susan Harran - Dallas TX, US Keith Combrink - Fort Worth TX, US Timothy W. Morris - Coppell TX, US
Rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms are claimed in this invention. The inventive rifamycin derivatives are uniquely designed in that they have a rifamycin moiety covalently linked to a linker group through the C-3 carbon of the rifamycin moiety and the linker is, in turn covalently linked to a therapeutic moiety or antibacterial agent/pharmacophore. The therapeutic moiety can be a quinolone, an oxazolidinone, a macrolide, an aminoglycoside, a tetracycline core or a structure/pharmacophore associated with an antibacterial agent.
Rifamycin C-11 Oxime Derivatives Effective Against Drug-Resistant Microbes
The invention relates to rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms, specifically, the rifamycin derivatives having an oxime group at the C-11 position.
Foster City, CA12 years of broad experience in Pharmaceutical and Biotech industry:
Commercial Strategy / Strategic Marketing: Product Commercialization and Launch
... 12 years of broad experience in Pharmaceutical and Biotech industry:
Commercial Strategy / Strategic Marketing: Product Commercialization and Launch
Product Management and Pharmaceutical Sales
Strategic Planning & Business Development: M & A and In-licensing Assessment
Matrix...